StonvexLoading…
StonvexStonvexStonvexCore line items from TOUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $82.65M | $70.37M | $62.15M | $26.62M |
Operating Income | $1.61M | $8.67M | $-14.35M | $-30.48M |
Net Income | $4.45M | $10.57M | $-13.99M | $-28.04M |
EPS (Diluted) | $0.01 | $0.03 | $-0.04 | $-0.08 |
Total Assets | $228.79M | $261.59M | $276.13M | $272.27M |
Total Liabilities | $91.79M | $123.36M | $138.12M | $118.83M |
Cash & Equivalents | $29.63M | $63.70M | $53.38M | $22.30M |
Free Cash Flow OCF − CapEx | $-16.62M | $11.57M | $31.42M | $-21.67M |
Shares Outstanding | 327.63M | 351.16M | 389.33M | 389.33M |